Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases

[1]  T. Young-Pearse,et al.  Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain. , 2021, Brain : a journal of neurology.

[2]  G. Schellenberg,et al.  TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy , 2021, Science advances.

[3]  Pitter F. Huesgen,et al.  The Peptide Ligase Activity of Human Legumain Depends on Fold Stabilization and Balanced Substrate Affinities , 2021, ACS catalysis.

[4]  A. Burlingame,et al.  Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration , 2021, Molecular Neurodegeneration.

[5]  A. Singleton,et al.  Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH , 2021, Neuron.

[6]  T. Kukar,et al.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis , 2021, Neurobiology of Disease.

[7]  W. Surewicz,et al.  Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43 , 2020, Nature Communications.

[8]  M. Polymenidou,et al.  Phase Separation and Neurodegenerative Diseases: A Disturbance in the Force. , 2020, Developmental cell.

[9]  R. Pappu,et al.  Beyond aggregation: Pathological phase transitions in neurodegenerative disease , 2020, Science.

[10]  S. Smaili,et al.  α-Synuclein Overexpression Induces Lysosomal Dysfunction and Autophagy Impairment in Human Neuroblastoma SH-SY5Y , 2020, Neurochemical Research.

[11]  Jennifer C. Lee,et al.  Cathepsin K is a potent disaggregase of α-synuclein fibrils. , 2020, Biochemical and biophysical research communications.

[12]  A. Burlingame,et al.  Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration , 2020, Molecular Neurodegeneration.

[13]  Chonglin Yang,et al.  Lysosome activity is modulated by multiple longevity pathways and is important for lifespan extension in C. elegans , 2020, eLife.

[14]  L. Golbe,et al.  Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons , 2020, Scientific Reports.

[15]  John L. Robinson,et al.  The development and convergence of co-pathologies in Alzheimer's disease. , 2020, Brain : a journal of neurology.

[16]  M. Khanna,et al.  Structural Insights Into TDP-43 and Effects of Post-translational Modifications , 2019, Front. Mol. Neurosci..

[17]  Yan Liu,et al.  Proteasome Inhibition Activates Autophagy-Lysosome Pathway Associated With TFEB Dephosphorylation and Nuclear Translocation , 2019, Front. Cell Dev. Biol..

[18]  Victoria J. Butler,et al.  Age- and stress-associated C. elegans granulins impair lysosomal function and induce a compensatory HLH-30/TFEB transcriptional response , 2019, PLoS genetics.

[19]  L. Stefanis,et al.  How is alpha‐synuclein cleared from the cell? , 2019, Journal of neurochemistry.

[20]  D. Eisenberg,et al.  Cryo-EM Structures of Four Polymorphic TDP-43 Amyloid Cores , 2019, bioRxiv.

[21]  C. Craik,et al.  Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH. , 2019, Journal of molecular biology.

[22]  T. Golde,et al.  MAPT mutations, tauopathy, and mechanisms of neurodegeneration , 2019, Laboratory Investigation.

[23]  M. Hipp,et al.  The proteostasis network and its decline in ageing , 2019, Nature Reviews Molecular Cell Biology.

[24]  D. Eisenberg,et al.  Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel , 2018, Alzheimer's & Dementia.

[25]  Sonia Podvin,et al.  Lysosomal Cathepsin Protease Gene Expression Profiles in the Human Brain During Normal Development , 2018, Journal of Molecular Neuroscience.

[26]  Fu-Rong Sun,et al.  Tau in neurodegenerative disease. , 2018, Annals of translational medicine.

[27]  T. Golde,et al.  Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies. , 2018, The Journal of Biological Chemistry.

[28]  E. Passegué,et al.  Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging , 2018, Science.

[29]  T. Südhof,et al.  Cell Biology and Pathophysiology of α-Synuclein. , 2018, Cold Spring Harbor perspectives in medicine.

[30]  Luwen Wang,et al.  Pathomechanisms of TDP‐43 in neurodegeneration , 2018, Journal of neurochemistry.

[31]  A. Atanasov,et al.  Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications , 2018, Front. Aging Neurosci..

[32]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[33]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[34]  S. Lorenzl,et al.  Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy , 2017, Experimental Brain Research.

[35]  Tuancheng Feng,et al.  Regulation of cathepsin D activity by the FTLD protein progranulin , 2017, Acta Neuropathologica.

[36]  B. Wieringa,et al.  The SH-SY5Y cell line in Parkinson’s disease research: a systematic review , 2017, Molecular Neurodegeneration.

[37]  Dennis W Dickson,et al.  Pathology of Neurodegenerative Diseases. , 2017, Cold Spring Harbor perspectives in biology.

[38]  Roberto Zoncu,et al.  The Lysosome as a Regulatory Hub. , 2016, Annual review of cell and developmental biology.

[39]  D. Bennett,et al.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. , 2016, Brain : a journal of neurology.

[40]  K. Ye,et al.  Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases , 2016, Expert opinion on therapeutic targets.

[41]  A. Cuervo,et al.  Proteostasis and aging , 2015, Nature Network Boston.

[42]  N. Modugno,et al.  Four Copies of SNCA Responsible for Autosomal Dominant Parkinson's Disease in Two Italian Siblings , 2015, Parkinson's disease.

[43]  H. Nakanishi,et al.  The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage , 2015, The Journal of Neuroscience.

[44]  Jennifer C. Lee,et al.  Cysteine cathepsins are essential in lysosomal degradation of α-synuclein , 2015, Proceedings of the National Academy of Sciences.

[45]  Andrew Folick,et al.  Lysosomal signaling molecules regulate longevity in Caenorhabditis elegans , 2015, Science.

[46]  P. Majumder,et al.  Metabolism and mis-metabolism of the neuropathological signature protein TDP-43 , 2014, Journal of Cell Science.

[47]  S. Antonyuk,et al.  Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life , 2014, Proceedings of the National Academy of Sciences.

[48]  D. Vilchez,et al.  The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases , 2014, Current genomics.

[49]  D. Burks,et al.  Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor , 2013, PloS one.

[50]  T. Südhof,et al.  Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.

[51]  Min Jae Lee,et al.  Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system , 2013, Progress in Neurobiology.

[52]  Ewout J. N. Groen,et al.  Protein aggregation in amyotrophic lateral sclerosis , 2013, Acta Neuropathologica.

[53]  E. Masliah,et al.  The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.

[54]  Geoffrey I. Webb,et al.  PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites , 2012, PloS one.

[55]  D. Rubinsztein,et al.  Autophagy and misfolded proteins in neurodegeneration , 2012, Experimental Neurology.

[56]  D. Gottschling,et al.  An Early-Age Increase in Vacuolar pH Limits Mitochondrial Function and Lifespan in Yeast , 2012, Nature.

[57]  Alma L Burlingame,et al.  Global identification of peptidase specificity by multiplex substrate profiling , 2012, Nature Methods.

[58]  M. Platt,et al.  Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues. , 2011, Archives of biochemistry and biophysics.

[59]  O. Schilling,et al.  Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S. , 2011, Journal of proteome research.

[60]  Olga Vasiljeva,et al.  Cysteine cathepsins: From structure, function and regulation to new frontiers , 2011, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.

[61]  Huilin Zhou,et al.  ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.

[62]  K. Gevaert,et al.  Improved visualization of protein consensus sequences by iceLogo , 2009, Nature Methods.

[63]  Valerio Embrione,et al.  A Gene Network Regulating Lysosomal Biogenesis and Function , 2009, Science.

[64]  Anil K. Jain.  Data clustering: 50 years beyond K-means , 2008, Pattern Recognit. Lett..

[65]  S. Yen,et al.  Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. , 2008, Biochemistry.

[66]  Marc Cruts,et al.  Loss of progranulin function in frontotemporal lobar degeneration. , 2008, Trends in genetics : TIG.

[67]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[68]  A. Lehesjoki,et al.  Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. , 2006, Brain : a journal of neurology.

[69]  L. Juliano,et al.  Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L. , 2004, Archives of biochemistry and biophysics.

[70]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[71]  L. Hedstrom.  Serine protease mechanism and specificity. , 2002, Chemical reviews.

[72]  H. Kalbacher,et al.  Characterization of Legumain , 2002, Biological chemistry.

[73]  S. Yen,et al.  Degradation of Tau by Lysosomal Enzyme Cathepsin D: Implication for Alzheimer Neurofibrillary Degeneration , 1997, Journal of neurochemistry.

[74]  H. Nakanishi,et al.  Increased Expression of Cathepsins E and D in Neurons of the Aged Rat Brain and Their Colocalization with Lipofuscin and Carboxy‐Terminal Fragments of Alzheimer Amyloid Precursor Protein , 1997, Journal of neurochemistry.

[75]  A. Lajtha,et al.  The pH dependence of breakdown of various purified brain proteins by cathepsin D preparations , 1985, Neurochemistry International.

[76]  OUP accepted manuscript , 2021, Brain.

[77]  N. Rawlings.  Using the MEROPS Database for Investigation of Lysosomal Peptidases, Their Inhibitors, and Substrates. , 2017, Methods in molecular biology.

[78]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[79]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.